LAP3 Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amastatin hydrochloride | 100938-10-1 | sc-202051 sc-202051A | 1 mg 5 mg | $72.00 $214.00 | 3 | |
Amastatin hydrochloride functions as a potent inhibitor of aminopeptidases, showcasing a unique ability to bind selectively to the enzyme's active site. Its structural conformation allows for specific interactions with substrate recognition sites, enhancing its inhibitory efficacy. The compound's kinetic profile reveals a rapid association and a slower dissociation rate, contributing to prolonged enzyme inhibition. Additionally, its solubility characteristics facilitate effective distribution in various biochemical contexts, impacting its interaction with target enzymes. | ||||||
Bestatin hydrochloride | 65391-42-6 | sc-200564 sc-200564A sc-200564B | 5 mg 25 mg 500 mg | $106.00 $352.00 $1132.00 | 1 | |
Bestatin hydrochloride acts as a selective inhibitor of leucine aminopeptidase 3 (LAP3), demonstrating a unique affinity for the enzyme's catalytic site. Its molecular structure enables precise interactions with key residues, influencing substrate binding dynamics. The compound exhibits a distinctive reaction kinetics profile, characterized by a fast initial binding phase followed by a gradual stabilization, which enhances its inhibitory potential. Furthermore, its hydrophilic nature promotes effective solvation, optimizing its interaction with LAP3 in diverse biochemical environments. | ||||||
Bestatin | 58970-76-6 | sc-202975 | 10 mg | $128.00 | 19 | |
Inhibits aminopeptidases, potentially reducing LAP3 activity by preventing the cleavage of amino-terminal residues from peptides. | ||||||
Di-p-toluoyl-L-tartaric acid monohydrate | 71607-32-4 | sc-337657 sc-337657A | 25 g 100 g | $39.00 $99.00 | ||
Functions as an aminopeptidase inhibitor, which can inhibit LAP3 by blocking the hydrolysis of amino acid residues from peptides. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can increase intracellular peptide levels, potentially decreasing LAP3 activity due to feedback inhibition. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Another proteasome inhibitor that, by increasing peptide concentrations, can lead to reduced LAP3 activity by a similar mechanism as MG132. | ||||||
CHR 2797 | 238750-77-1 | sc-285285 sc-285285A | 1 mg 10 mg | $119.00 $255.00 | ||
A metalloenzyme inhibitor that inhibits aminopeptidases, which may reduce LAP3 activity. | ||||||
LY411575 | 209984-57-6 | sc-364529 sc-364529A | 10 mg 50 mg | $194.00 $464.00 | 6 | |
A selective aminopeptidase inhibitor that can inhibit LAP3 by blocking the processing of peptide substrates. | ||||||
4-Guanidinobutyric acid | 463-00-3 | sc-252156 sc-252156A | 1 g 5 g | $66.00 $260.00 | ||
Competes with substrates for LAP3 binding, potentially inhibiting LAP3 activity by preventing substrate interaction. | ||||||
Actinonin | 13434-13-4 | sc-201289 sc-201289B | 5 mg 10 mg | $160.00 $319.00 | 3 | |
An antibiotic that inhibits various aminopeptidases and can decrease LAP3 activity by preventing peptide cleavage. | ||||||